AL
TGT icon

Aspiriant LLC’s Target TGT Stock Holding History

Aspiriant LLC’s Portfolio TGT Stock Details TGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
+2,208
New +$281K 0.01% 327
2025
Q1 		– Sell
-1,618
Closed -$219K – 304
2024
Q4 		$219K Buy
1,618
+152
+10% +$21.8K 0.01% 273
2024
Q3 		$228K Sell
1,466
-210
-13% -$31.3K 0.01% 264
2024
Q2 		$248K Sell
1,676
-641
-28% -$101K 0.01% 254
2024
Q1 		$411K Buy
2,317
+158
+7% +$24K 0.02% 215
2023
Q4 		$307K Buy
2,159
+112
+5% +$13.7K 0.01% 237
2023
Q3 		$226K Buy
2,047
+400
+24% +$50.8K 0.01% 256
2023
Q2 		$217K Sell
1,647
-60
-4% -$8.9K 0.01% 266
2023
Q1 		$283K Buy
1,707
+40
+2% +$6.58K 0.01% 226
2022
Q4 		$248K Buy
1,667
+78
+5% +$12.2K 0.01% 239
2022
Q3 		$235K Buy
1,589
+97
+7% +$15.5K 0.01% 233
2022
Q2 		$211K Sell
1,492
-51
-3% -$9.78K 0.01% 261
2022
Q1 		$327K Sell
1,543
-55
-3% -$11.9K 0.02% 217
2021
Q4 		$371K Buy
1,598
+95
+6% +$23.1K 0.02% 205
2021
Q3 		$344K Sell
1,503
-75
-5% -$18.8K 0.02% 184
2021
Q2 		$380K Sell
1,578
-186
-11% -$40.7K 0.02% 180
2021
Q1 		$351K Sell
1,764
-90
-5% -$16.8K 0.02% 166
2020
Q4 		$327K Sell
1,854
-2,316
-56% -$386K 0.02% 167
2020
Q3 		$656K Buy
+4,170
New +$572K 0.05% 134
2017
Q1 		– Sell
-13,136
Closed -$949K – 225
2016
Q4 		$949K Buy
13,136
+4,451
+51% +$322K 0.09% 111
2016
Q3 		$596K Sell
8,685
-1,322
-13% -$94.8K 0.06% 128
2016
Q2 		$816K Buy
10,007
+2,470
+33% +$184K 0.08% 113
2016
Q1 		$620K Buy
+7,537
New +$569K 0.06% 121

Other funds holding TGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aspiriant LLC's TGT Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Target (TGT) in Q2 2026: 2,208 shares worth $288K. The stake represents 0.01% of the portfolio and ranks #327 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in TGT as recently as Q4 2024.

Aspiriant LLC first reported a position in TGT in Q1 2016 and has held it in 23 quarters since. The position peaked at $949K in Q4 2016. 1,887 funds tracked by Wall St. Rank hold TGT as of Q2 2026.

  • Aspiriant LLC held 2,208 shares of Target worth $288K as of Q2 2026.
  • Target was a new Aspiriant LLC position in Q2 2026.
  • Target made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #327 holding.
  • Aspiriant LLC first reported a position in Target in Q1 2016 and has held it in 23 quarters since.
  • Aspiriant LLC's Target position peaked at $949K in Q4 2016.
  • 1,887 funds tracked by Wall St. Rank held Target as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.